Hans Edgar Bishop Sana Biotechnology, Inc. (SANA) insider trading activity

Hans Edgar Bishop is of Sana Biotechnology, Inc.. Currently has a direct ownership of 5.82 Million shares of SANA, which is worth approximately $9.95 Million. The most recent transaction as insider was on Apr 07, 2025, when has been sold 16,339 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.82M

0.28% 3M change

0.72% 12M change

Total Value Held $9.95 Million

Hans Edgar Bishop Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 07 2025	BUY Grant, award, or other acquisition	-	16,339 Added 0.28%	5,821,113 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	14,285 Added 0.25%	5,804,774 Common Stock
Oct 07 2024	BUY Grant, award, or other acquisition	-	5,938 Added 0.1%	5,790,489 Common Stock
Jul 05 2024	BUY Grant, award, or other acquisition	-	4,911 Added 0.08%	5,784,551 Common Stock
Apr 05 2024	BUY Grant, award, or other acquisition	-	2,774 Added 0.05%	5,779,640 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	4,901 Added 0.08%	5,776,866 Common Stock
Oct 05 2023	BUY Grant, award, or other acquisition	-	6,925 Added 0.12%	5,771,965 Common Stock
Jul 05 2023	BUY Grant, award, or other acquisition	-	4,152 Added 0.07%	5,765,040 Common Stock
Apr 05 2023	BUY Grant, award, or other acquisition	-	7,716 Added 0.13%	5,760,888 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	6,702 Added 0.12%	5,753,172 Common Stock
Oct 05 2022	BUY Grant, award, or other acquisition	-	4,012 Added 0.07%	5,746,470 Common Stock
Jul 05 2022	BUY Grant, award, or other acquisition	-	3,328 Added 0.06%	5,742,458 Common Stock
Apr 05 2022	BUY Grant, award, or other acquisition	-	2,880 Added 0.05%	5,739,130 Common Stock
Feb 08 2021	BUY Conversion of derivative security	-	2,031,250 Added 26.15%	5,736,250 Common Stock

Also insider at

AGILENT TECHNOLOGIES, INC. Healthcare

Director

LYEL

Lyell Immunopharma, Inc. Healthcare

HEB